47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
68.10.Z - Real estate activities on own account and development of building projects
68.31.Z - Real estate brokerage
69.20.Z - Accounting, bookkeeping and tax consultancy
73.12.D - Advertising through mass media
82.99.Z - Other business support activities, not elsewhere classified
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,3 | 2,9 | 3,9 | 35,2 |
EBITDA | 4,5 | 3,5 | 4,3 | 24 |
Short time liabilities | 8,7 | 9,8 | 9 | -9 |
Equity capital | 5 | 5,3 | 7 | 31,2 |
Operating profit (EBIT) | 4,1 | 2,9 | 4 | 35,2 |
Assets | 14,5 | 15,7 | 16,5 | 5,2 |
Net profit (loss) | 5,3 | 2,9 | 3,9 | 35,2 |
Cash | 1,7 | 4,2 | 1,9 | -54,8 |
Net income from sale | 69,9 | 78,9 | 82,5 | 4,6 |
Liabilities and provisions for liabilities | 9,5 | 10,4 | 9,5 | -8,2 |
Working assets | 10,6 | 14,1 | 14,4 | 2,1 |
Depreciation | 0,4 | 0,5 | 0,4 | -35,9 |
% | % | % | p.p. | |
Profitability of capital | 104,9 | 54,5 | 56,2 | 1,7 |
Equity capital to total assets | 34,5 | 33,9 | 42,4 | 8,5 |
Gross profit margin | 7,5 | 3,7 | 4,8 | 1,1 |
EBITDA Margin | 6,5 | 4,4 | 5,2 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 45 | 46 | 40 | -6 |
Current financial liquidity indicator | 0,1 | |||
Net dept to EBITDA | -1,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane